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Abstract: The neurotoxicity of β-amyloid protein (AβP) is implicated in the etiology of 
Alzheimer’s disease. We previously have demonstrated that AβP forms Ca2+-permeable pores 
on neuronal membranes, causes a marked increase in intracellular calcium level, and leads 
to neuronal death. Here, we investigated in detail the features of AβP-induced changes in 
intracellular Ca2+ level in primary cultured rat hippocampal neurons using a multisite Ca2+-
imaging system with fura-2 as a ﬂ  uorescent probe. Only a small fraction of short-term cultured 
hippocampal neurons (ca 1 week in vitro) exhibited changes in intracellular Ca2+ level after 
AβP exposure. However, AβP caused an acute increase in intracellular Ca2+ level in long-term 
cultured neurons (ca 1 month in vitro). The responses to AβP were highly heterogeneous, and 
immunohistochemical analysis using an antibody to AβP revealed that AβP is deposited on 
some but not all neurons. Considering that the disruption of Ca2+ homeostasis is the primary 
event in AβP neurotoxicity, substances that protect neurons from an AβP-induced intracellular 
Ca2+ level increase may be candidates as therapeutic drugs for Alzheimer’s disease. In line 
with the search for such protective substances, we found that the preadministration of neuros-
teroids including dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pregnenolone 
signiﬁ  cantly inhibits the increase in intracellular calcium level induced by AβP. Our results 
suggest the possible signiﬁ  cance of neurosteroids, whose levels are reduced in the elderly, in 
preventing AβP neurotoxicity.
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Introduction
Alzheimer’s disease (AD) is a senile type of dementia affecting many of the elderly. 
AD is pathologically characterized by selective neuronal loss, and the presence of 
numerous extracellular deposits termed senile plaques and intraneuronal neuroﬁ  bril-
lary tangles (NFTs) in the patient’s brain (Selkoe 1991). The principal constituent of 
senile plaques is the β-amyloid protein (AβP), which is a peptide composed of 38–43 
amino acids and a proteolytic product of a large precursor protein (amyloid precursor 
protein; APP). Genetic studies of early-onset cases of familial AD indicated that 
APP mutations and AβP metabolism are associated with the disease (Goate et al 
1991). Yankner and colleagues found that the segment comprising the ﬁ  rst 40 amino 
acid residues of AβP, termed AβP[1–40], has neurotoxic effects on primary cultured 
neurons of the rat hippocampus (Yankner et al 1990). These lines of evidence support 
the idea that AβP and its neurotoxicity might be causal agents of neuronal death in 
AD patients (Small et al 2001).
Although the molecular mechanism underlying AβP neurotoxicity is not yet fully 
understood, there are a growing number of studies suggesting that the disruption of Ca2+ Neuropsychiatric Disease and Treatment 2008:4(1) 210
Kato-Negishi and Kawahara
homeostasis is crucial to AβP neurodegeneration (Mattson 
et al 1992; Fraser et al 1997). We previously showed that 
AβP[1–40] is directly incorporated into membranes excised 
from GT1–7 cells, which are derived from the tumorigenesis 
of murine hypothalamic neurons, and forms unregulated cat-
ion-selective (including Ca2+) ion channels (Kawahara et al 
1997). The characteristics of channels formed by AβP, ie, 
‘amyloid channels’, on membranes of GT1–7 cells are similar 
to those of channels formed on artiﬁ  cial planar lipid mem-
branes (Arispe et al 1993a, 1993b, 1996). Other neurotoxic 
AβP fragments such as AβP[25–35] and AβP[1–42], and 
the C-terminal fragment peptide of APP termed CT105 were 
also reported to form ion channels on artiﬁ  cial lipid bilayers 
or membranes of cultured neurons (Furukawa et al 1994; 
Mirzabecov et al 1994; Fraser et al 1996; Rhee et al 1998; 
Hirakura et al 1999). Furthermore, we have demonstrated that 
AβP[1–40], AβP[25–35] and AβP[1–42] cause the increase 
in intracellular Ca2+ level ([Ca2+]i) in GT1–7 cells (Kawahara 
et al 2000; Kawahara and Kuroda 2001; Kawahara 2004). 
Pretreatment with 2-amino-5-phosphonovalerate (D-APV; an 
antagonist of the N-methyl-D-aspartate (NMDA)-type gluta-
mate receptor), tetrodotoxin (TTX; a Na+ channel blocker), 
or nifedipine (an L-type Ca2+ channel blocker) has no effect 
on the AβP-induced [Ca2+]i increase (Kawahara 2004). On 
the basis of these lines of evidences, we hypothesized that 
the ability of AβP to form unregulated ‘amyloid channels’ 
across neuronal membranes and the resulting disruption of 
calcium homeostasis explain the molecular mechanism of 
AβP neurotoxicity (Pollard et al 1995; Kawahara 2004). This 
mechanism of AβP neurotoxicity is similar to that of the tox-
icity of toxins, venoms, or the complement system (Tomita 
et al 1992; Bechinger 1997; Kobayashi et al 2004).
Here, we applied AβP[1–40] and/or AβP[25–35] to 
cultured hippocampal neurons and observed the spatiotem-
poral changes in [Ca2+]i induced by AβP using a multisite 
Ca2+-imaging system with fura-2 as a ﬂ  uorescent probe. This 
system enables the simultaneous detection of temporal [Ca2+]i 
changes in cultured neurons facilitating statistical analysis. 
In this study, we investigated in detail the features of AβP-
induced [Ca2+]i changes and observed heterogeneous cell-
to-cell responses to AβP in cultured hippocampal neurons. 
The localization of AβP to the plasma membrane regions 
of the neurons was also observed by laser confocal micros-
copy using immunohistochemistry after AβP exposure. 
Furthermore, we found that AβP caused an acute increase 
in [Ca2+]i in many long-term cultured neurons. However, 
changes in intracellular Ca2+ level after AβP exposure were 
rarely observed among the short-term cultured hippocampal 
neurons. Therefore, the difference in susceptibility to AβP 
among neurons cultured for different periods was also 
examined.
Thus, the search for substances that protect against AβP 
neurotoxicity is crucial. Our system for observing Ca2+ 
inﬂ  ux induced by AβP has contributed to the search for 
such substances (Kawahara and Kuroda 2001). It requires a 
relatively short time for carrying out assays. The elevation of 
[Ca2+]i is considered to be the primary event of AβP neuro-
toxicity. We previously demonstrated that several lipophilic 
substances such as phloretin, cholesterol, and 17β-estradiol 
signiﬁ  cantly inhibit the AβP-induced elevation of [Ca2+]i 
in GT1–7 cells (Kawahara and Kuroda 2001). Phloretin, 
a plant-derived ﬂ  avonoid, decreases membrane potential 
and inhibits the electrostatic interaction between AβP and 
membrane lipids (Hertel et al 1997). Cholesterol decreases 
membrane ﬂ  uidity and inhibits channel formation by peptides 
(Tomita et al 1992). Cholesterol also blocks the increase in 
[Ca2+]i induced by AβP in cultured neurons (Hartmann et al 
1994). 17β-estradiol, a female hormone, is neuroprotec-
tive and affects membrane ﬂ  uidity (Schwartz et al 1996). 
All these compounds inhibit AβP neurotoxicity (Zhou and 
Richardson 1996; Hertel et al 1997; Olivieri et al 2002). 
Therefore, substances that modulate membrane properties 
such as membrane potential and ﬂ  uidity may inhibit AβP 
neurotoxicity. In line with the search for neuroprotective 
agents, we focused on neurosteroids including dehydro-
epiandrosterone (DHEA), dehydroepiandrosterone sulfate 
(DHEA-S), and pregnenolone. These neurosteroids are 
steroid hormones synthesized de novo in the central nervous 
system from cholesterol or peripheral steroid precursors. 
Several lines of evidence suggest that neurosteroids modulate 
various functions of the brain and exhibit neuroprotective 
activities (Tsutsui et al 2000). For example, DHEA-S could 
protect neurons from NMDA-induced neurotoxicity (Chara-
lampopoulos et al 2006). In addition, there is an age-related 
decrease in the levels of neurosteroids (Moffat et al 2000), 
and the levels of neurosteroids in plasma or in the brain are 
decreased in Alzheimer’s patients (Hillen et al 2000; Marx 
et al 2006). Thus, neurosteroids have been recognized as 
anti-aging hormones, and are widely used as supplements 
for improving the impaired cognitive functions of the elderly 
(Huppert et al 2000).
Experimental procedures
Chemicals and reagents
AβP[1–40] was obtained from Bachem F.A.G. (Bubendorf, 
Switzerland). AβP[25–35] was obtained from AnaSpec Inc. Neuropsychiatric Disease and Treatment 2008:4(1) 211
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(CA, USA). These peptides were dissolved in distilled water 
at 0.2 mM and stored at −80 °C. DHEA-S, DHEA, and preg-
nenolone were obtained from Sigma Ltd. (St. Louis, USA), 
and dissolved in dimethylsulfoxide (DMSO) at 10 mM.
Cell culture
The hippocampus was dissected out from fetal rats (18-day 
embryonic stage) and neurons were cultured by the method 
of Banker and Cowan with slight modiﬁ  cations (Banker 
and Cowan 1977; Muramoto et al 1993). Brieﬂ  y, after the 
removal of meninges, tissues were dissociated by mechanical 
trituration following digestion with 0.15 units/ml papain in 
phosphate-buffered saline (PBS) containing 0.02% L-cystein, 
0.02% BSA, and 0.5% glucose. Dissociated neurons were 
placed on polyethylenimine-coated coverslips and cultured 
in Dulbecco’s modiﬁ  ed Eagle’s medium (DMEM) supple-
mented with 5% horse serum, 5% newborn calf serum, and 
1 mM sodium pyruvate. The culture was maintained in a 
humidiﬁ  ed atmosphere of 93% air and 7% CO2 at 37 ° C. After 
3 days in vitro, the medium was replaced with serum-free 
DMEM supplemented with B27 (Gibco BRL, USA). The 
medium was changed every 3 days.
Intracellular free-calcium concentration 
measurements
The culture medium was replaced with a basal salt solution 
(BSS; in mM: 130 NaCl, 5.5 glucose, 5.4 KCl, 1.8 CaCl2, 
20 sodium HEPES, pH 7.4) containing 1.5 mM fura-2 AM 
(acetoxymethylester cell-permeant form, Molecular Probes, 
Oregon, USA). The cultured neurons were incubated with 
fura-2 AM at 37 °C for 60 min, washed and replaced with 
BSS containing 1 µM TTX to inhibit the endogenous changes 
in [Ca2+]i related to spontaneous synaptic ﬁ  rings (Robinson 
et al 1993), and then observed under an inverted ﬂ  uorescence 
microscope (Nikon, Japan) equipped with a high-resolution 
video camera (C-2400, Hamamatsu Photonics Co., Japan). 
Fluorescence images correspond to [Ca2+]i were recorded at a 
rate of 30 images/sec on VCR tapes and analyzed using an ad-
hoc hardware and software system controlled by a computer 
(FC-300, Mitsubishi Kasei, Japan). Each image represents the 
ﬂ  uorescence intensity from a rectangular optical ﬁ  eld (360 × 
420 mm2), which enabled the monitoring of approximately 50 
neurons simultaneously. The system enabled the recording 
of the ratio of the intensity emitted at 510 nm from pixels 
of images obtained by alternating the excitation wavelength 
between 340 and 360 nm using a rotating ﬁ  lter wheel. Each 
ratio was converted into [Ca2+]i using a calibration curve 
(ratio versus [Ca2+]i).
As a rule, prior to AβP addition to the bath solution of 
the cells, we recorded the resting levels of neuronal [Ca2+]i 
during a 5-min period. During the experiments, we added 
aliquots of the peptide stock solution directly to the bath 
solution (approximately 0.4 ml) of the cells. All recordings 
were obtained at 37 °C.
Immunohistochemistry
AβP[1–40] (2.5 µM) was applied onto hippocampal neurons 
cultured for 29 days in vitro (DIV). After 48 h, the cultured 
neurons were ﬁ  xed with 4% paraformaldehyde in Ca2+- and 
Mg2+-free PBS. After ﬁ  xation, the cultured neurons were 
incubated in PBS containing 0.5% saponin (Sigma Aldrich, 
St. Louis, USA) and 5% normal goat serum (Vector, UK) 
at 37 °C for 30 min to render the cell membranes perme-
able and to block nonspeciﬁ  c binding sites. The cultured 
neurons were incubated with primary antibodies diluted 
with 10% Block Ace (Dai-nihon Seiyaku, Japan) in PBS at 
4 °C overnight. For double-immunoﬂ  uorescence staining, a 
combination of a mouse monoclonal antibody and a rabbit 
polyclonal antibody was added to the cell preparation. An 
anti-microtubule associated protein 2 (MAP2) antibody 
(1:500, monoclonal, obtained from Boehringer Mannheim, 
Darmstadt, Germany) and an anti-AβP antibody (1:100, 
polyclonal, anti-N terminus of human AβP[1-40], obtained 
from IBL, Tokyo, Japan) were used as primary antibod-
ies. Thereafter, the cells were incubated with anti-mouse 
Ig, biotinylated species-speciﬁ  c whole antibody (1:500, 
Amersham Pharmacia Biotech Ltd., Buckinghampshire, 
England), and then with an FITC-conjugated goat anti- rabbit 
IgG antibody (1:500, Cappel) and Texas red-conjugated 
streptavidin (1:500, Bio-Rad Laboratories, California, 
USA). Stained cells were observed under a confocal laser 
scanning microscope (LSM 510; Zeiss).
Pretreatment with neurosteroids
Prior to the 20–30 min exposure to AβP, the solutions of 
DHEA-S, DHEA, and pregnenolone were diluted with BSS 
and were added to the bath solution of the neurons. There-
after, we carried out the same protocol designed to test the 
effects of AβP. As a control, 0.5% DMSO was applied to the 
cultured neurons, followed by 20 µM AβP[25–35].
Statistical analyses
Our system enabled the accurate measurement of the ampli-
tude of the peak [Ca2+]i increase (∆[Ca2+]i) in the response. 
To construct histograms from these data, we grouped the 
cell responses in bins (bin width, 20 nM) and then plotted Neuropsychiatric Disease and Treatment 2008:4(1) 212
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the number of cells/bin as a function of peak [Ca2+]i . We 
obtained both the mean amplitude of the early peak [Ca2+]i for 
each neuron and the mean percentage of cells responding to 
AβP. Data are expressed as means ± standard error of mean 
(SEM) of 25 to 50 neurons in one optical ﬁ  eld. All statistical 
evaluations were carried out using a two-tailed Student’s t-
test using Stat View (SAS Institute, NC, USA). A probability 
level of  0.05 was considered to be signiﬁ  cant.
Results
Effects of culture period on AβP-induced 
[Ca2+]i changes
We applied AβP[25–35] (20 µM) solution to rat hippo-
campal neurons at various culture periods and observed the 
time course of [Ca2+]i. Little or no changes were observed 
in [Ca2+]i after AβP exposure in short-term cultured hip-
pocampal neurons. On the other hands, a large proportion 
of long-term cultured neurons exhibited a marked increase 
in [Ca2+]i. Figure 1A shows traces of the temporal changes 
in [Ca2+]i induced by 20 µM AβP[25–35] at 8 DIV and 35 
DIV in 10 randomly chosen neurons in one optical ﬁ  eld. 
The extent of increase in [Ca2+]i induced by AβP was differ-
ent among cultured neurons even in the same optical ﬁ  eld. 
Therefore, we obtained the amplitude of the peak [Ca2+]i 
increase (∆[Ca2+]i) in each neuron and the percentage of 
neurons responding to AβP in an optical ﬁ  eld for statistical 
analysis. Figure 1B shows the histograms constructed from 
measurements of ∆[Ca2+]i in each neuron at 8 DIV and 35 
DIV. In the panels, the vertical axes represent the percent-
age of neurons responding to AβP, and the horizontal axes 
represent the amplitude of ∆[Ca2+]i (bin = 20 nM). From these 
histograms, we obtained the mean amplitude of the increase 
in [Ca2+]i over basal [Ca2+]i (∼100 nM) in hippocampal neu-
rons and the proportion of cultured neurons (in percentage) 
that responded with a characteristic [Ca2+]i increase. At 8 
DIV, the percentage of cells responding to AβP was 8 ± 7 % 
(mean ± SEM, n = 5), and the mean [Ca2+]i increase was 
19 ± 3 nM (mean ± SEM, n = 250). On the other hand, at 35 
DIV, the same AβP[25–35] concentration increased [Ca2+]i 
to 311 ± 37 nM (mean ± SEM, n = 250) in 79 ± 3% (mean ± 
SEM, n = 5) of neurons in the same optical ﬁ  eld.
Heterogeneity of cell-to-cell responses
to AβP
Further detailed analysis of the elevation of [Ca2+]i in many 
neurons in the same optical ﬁ  eld revealed that the type of 
response of one neuron to AβP was not identical to that of 
another neuron and that not all neurons exhibited [Ca2+]i 
increase after the AβP addition. As shown in Figure 1A (b), 
the cell-to-cell responses to AβP were highly heterogeneous 
among neighboring neurons. The variability in neuronal 
responses is similar to our previous work using genetically 
identical GT1–7 cells, which exhibit heterogeneous responses 
after their exposure to AβP[25–35] as well as AβP[1–40] 
(Kawahara et al 2000; Kawahara and Kuroda 2001). The 
responses of 20 randomly chosen neurons in the same ﬁ  eld of 
view before and after the application of AβP[1–40] were ana-
lyzed and their traces are shown in Fig. 2A. The traces were 
aligned to the time of AβP[1–40] application. The magnitude 
of the peak [Ca2+]i increase, latency (the time of onset of the 
ﬁ  rst detectable increase in [Ca2+]i from the addition of AβP), 
and the pattern of [Ca2+]i changes differed among neurons. 
Some neurons showed an acute and a transient increase in 
[Ca2+]i within 5 min after the AβP[1–40] exposure (eg, cell 
nos. 6, 9, 10, 12, and 20 in Figure 2A), whereas [Ca2+]i in other 
neurons remained high at least 5 min after the exposure (cell 
nos. 2, 7, and 16). The delayed elevation of [Ca2+]i after the 
AβP exposure was observed in cell nos. 13, 15, 17, and 18. 
We observed no detectable elevation of [Ca2+]i in neighboring 
neurons (eg, cell nos. 4 and 14).
Furthermore, we applied AβP[1–40] at a sublethal level 
(2.5 µM) to cultured hippocampal neurons and observed 
AβP binding to membrane surfaces. Cultured neurons were 
ﬁ  xed and double-immunostained using antibodies to AβP 
and MAP2, a neuronal marker. Fluorescence images were 
observed under a laser confocal microscope. Figure 2B shows 
that the afﬁ  nities of AβP to neuronal membrane surfaces 
are also highly heterogeneous. AβP[1–40] was found to 
deposit on somata and dendrites in some neurons (labeled by 
asterisks in Figures 2B (a) and (d)); however, we found no 
detectable AβP[1–40] deposition on surfaces of neighbor-
ing neurons. Note that the morphological characteristics of 
these neurons were similar. Figures 2B (d)-(f) show higher-
magniﬁ  cation images of the same area shown in Figures 2B 
(a)-(c). The AβP[1–40] binding to neurons (asterisks) is not 
homogeneous. Moreover, AβP localizes to restricted areas 
of the somata and dendrites (Figure 2B (e)), whereas MAP2 
is homogeneously distributed (Figure 2B (d)).
Protection against AβP-induced [Ca2+]i 
increase by neurosteroids
We pretreated hippocampal neurons at 30–36 DIV with 
solutions of neurosteroids, namely, DHEA, DHEA-S, or 
pregnenolone to. After 20–30 min, cultured neurons were 
exposed to AβP[25–35] (20 µM) and the changes in [Ca2+]i Neuropsychiatric Disease and Treatment 2008:4(1) 213
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were observed using the same protocol. DHEA, DHEA-S, 
or pregnenolone at 25 µM signiﬁ  cantly inhibited the mean 
increase in [Ca2+]i induced by AβP[25–35] (Figure 3). The 
mean increases in [Ca2+]i in cultured neurons pretreated with 
DHEA, DHEA-S, or pregnenolone were 50 ± 9.2%, 0.7 ± 
0.5%, 13 ± 4% that of the control (neurons pretreated with 0.5 
% DMSO), respectively (mean ± SEM, n = 200) (Figure 3A). 
The percentages of neurons responding to AβP among those 
pretreated with DHEA, DHEA-S, and pregnenolone also 
decreased (Figure 3B).
The inhibition by DHEA-S was more marked than 
those by DHEA or pregnenolone. Figure 4A shows typical 
responses to AβP[25–35] (20 µM) with (b) or without (a) 
DHEA-S pretreatment (10 µM) in the same view ﬁ  eld. Figure 
4B shows the histograms constructed from measurements of 
the peak [Ca2+]i increase in each neuron. Figures 4C and 4D 
show the dose-dependent effects of DHEA-S on the mean 
increase in [Ca2+]i and the percentage of responding neurons 
induced by AβP[25–35], respectively. DHEA-S at 1 and 10 µM
inhibited the mean [Ca2+]i changes to 58 ± 15% and 35 ± 
7% that of control (pretreated with 0.5% DMSO) neurons, 
respectively (mean ± SEM, n = 250). In the case of using 
DHEA-S at more than 25 µM, most neurons exhibited no 
signiﬁ  cant increase in [Ca2+]i.
Figure 1 Patterns of [Ca2+]i increase in hippocampal neurons cultured at 8 DIV and 35 DIV induced by AβP[25–35]. A. Temporal changes in [Ca2+]i in 10 randomly chosen 
cultured hippocampal neurons at 8 DIV (a) and 35 DIV (b) in the same optical ﬁ  eld were analyzed, and their traces are shown.  Arrows indicate the time when 20 µM AβP[25–35] 
was added to the bath solution. B. Frequency histograms of extent of [Ca2+]i increase at 8 DIV (a) and 35 DIV (b). The vertical axes represent the percentage of neurons 
responding to AβP, and the horizontal axes represent the amplitude of the peak [Ca2+]i increase (bin = 20 nM).Neuropsychiatric Disease and Treatment 2008:4(1) 214
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Discussion
We observed the spatiotemporal changes in [Ca2+]i in cul-
tured rat hippocampal neurons induced by AβP[25–35] and 
AβP[1–40], both exhibiting β-sheet formation and neurotoxic-
ity. Our results indicate that long-term (ca 1 month) cultured 
neurons are more susceptible to AβP than short-term (ca 1 
week) cultured neurons. We have also demonstrated that the 
responses to AβP[25–35] as well as to AβP[1–40] are highly 
heterogeneous among neighboring cultured neurons and that 
AβP[1–40] has an afﬁ  nity to some type of neuron. Our results 
are in accordance with the previous results showing that 
AβP[1–40] induces changes in electrophysiological activities 
in 3- to 4-week-cultured rat cerebral cortical neurons (Hartley 
et al 1999). Although factors affecting the susceptibility of 
neurons to AβP are under investigation, it is widely accepted 
that the properties of membrane lipids including membrane 
ﬂ  uidity and the net charge of membrane surfaces are crucial to 
peptide binding and the subsequent channel formation (Terzi 
et al 1994). In particular, the changes in membrane properties 
such as the level ratio of cholesterol to other phopholipids 
during the in vitro development of cultured hippocampal 
neurons may be important. In particular, cholesterol decreases 
Figure 2 Heterogenic responses to AβP.  A. Patterns of [Ca2+]i increase in 20 hippocampal neurons induced by AβP[1–40]. Traces of temporal changes in [Ca2+]i in 20 ran-
domly chosen cultured hippocampal neurons in the same ﬁ  eld of view were analyzed. Numbers represent the number of cells used in the analysis. Arrows indicate the time 
at which 10 µM AβP[1–40] was added to the bath solution. B. Immunohistochemical identiﬁ  cation and localization of AβP[1–40] on cultured hippocampal neurons. Laser 
confocal microscopy images of cultured hippocampal neurons (29 DIV) after MAP2 binding (Texas Red, red) ((a) and (d)) and AβP binding (FITC, green) ((b) and (e)), and their 
superimposed images ((c) and (f)). Images (d)-(f) are images of the same areas shown in (a)-(c) at a higher magniﬁ  cation.Neuropsychiatric Disease and Treatment 2008:4(1) 215
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membrane ﬂ  uidity and thus inhibits the assembly of peptides 
(Fujii et al 1997). The addition of cholesterol to membrane 
lipids inhibits the formation of ion channels by prion fragment 
peptides (Mirzabekov 1994) or Staphylococcus aureus α-toxin 
(Tomita et al 1992). Numerous epidemiological studies have 
suggested that a genotype of apolipoprotein E (E4 allele), 
which plays important roles in the transfer and metabolism 
of cholesterol, is a risk factor for AD (Corder et al 1993) and 
that cholesterol is signiﬁ  cant in AD pathology (Hartmann 
2001). Cholesterol has been reported to block the elevation 
of [Ca2+]i induced by AβP (Hartmann et al 1994; Kawahara 
et al 2000), inhibit AβP neurotoxicity (Zhou and Richardson 
1996), and affect the secretion of AβP (Frears et al 1999). It is 
also possible that the percentage of neurons that are resistant 
to AβP neurotoxicity changes during in vitro development. In 
particular, gamma-aminobutyric acid (GABA)-immunoposi-
tive neurons may be important in the developmental change 
in susceptibility to AβP because of their resistance to AβP 
neurotoxicity (Pike and Cotman 1993). We have demonstrated 
that the developmental changes of GABAergic synapses occur 
at 7–14 DIV (Kato-Negishi et al 2004).
The search for protective agents against AβP neurotoxicity 
is of great importance. Our system for observing Ca2+ inﬂ  ux 
through AβP channels has contributed to the search for such 
substances (Kawahara and Kuroda 2001). In line with the 
search for protective agents, we found that neurosteroids 
including DHEA, DHEA-S, and pregnenolone signiﬁ  cantly 
inhibit the [Ca2+]i elevation induced by AβP. DHEA and 
DHEA-S have neuroprotective effects against excitotoxicity 
(Kimonides et al 1998). Considering that plasma DHEA-S 
level is reduced in healthy individuals in an age-dependent 
manner and in AD patients (Hillen et al 2000), the implication 
of DHEA-S in the pathogenesis of AD may be important. 
Although the mechanism that DHEA-S inhibits AβP-induced 
elevation of [Ca2+]i is still under investigation, it is possible 
that DHEA-S modulates membrane ﬂ  uidity or membrane 
potential, and inﬂ  uences the afﬁ  nity of AβP to membranes. 
Further research about the inﬂ  uences of DHEA-S on the 
AβP binding to membrane surfaces is necessary. Moreover, 
it is interesting that DHEA-S can modulate GABA receptors 
(Meyer et al 1999). Further studies of the mechanism under-
lying the differences in AβP susceptibility and the mechanism 
of inhibition by neurosteroids are necessary to conﬁ  rm the 
above possibilities. Our results are the ﬁ  rst to suggest the 
role of neurosteroids in AβP neurotoxicity and the develop-
ment of neurosteroids for AD treatment. In conclusion, our 
results may aid in improving our understanding of AD and 
the development of drugs for AD treatment.
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Figure 3 Effects of DHEA, DHEA-S, and pregnenolone on [Ca2+]i increase induced by AβP.  A. After a 20-min incubation period at 37 °C in 25 µM DHEA-S, DHEA, and preg-
nenolone (PG), the average increase in [Ca2+]i induced by 20 µM AβP[25–35] was determined.   As a control, the same DMSO concentration (0.5%) was added to the cultured 
neurons by the same protocol. Data are expressed as mean ± SEM, n = 200, ** p   0.001. B. Percentage of cells responding to AβP under same conditions as those in (A). 
Data are expressed as mean ± SEM, n = 5.Neuropsychiatric Disease and Treatment 2008:4(1) 216
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Figure 4 Effects of DHEA-S on AβP-induced [Ca2+]i increase.  A. Responses to AβP with or without DHEA-S pretreatment. After a 20-min incubation period at 37 °C with (b) 
or without (a) DHEA-S (10 µM), cultured hippocampal neurons (35 DIV) were exposed to 20 µM AβP[25–35]. Five typical traces of temporal changes in [Ca2+]i 2 min before 
and 5 min after the exposure in the same view ﬁ  eld are shown. B. Frequency histograms of extent of [Ca2+]i increase with or without DHEA-S pretreatment. The vertical axes 
represent the percentage of neurons responding to AβP, and the horizontal axes represent the amplitude of the peak [Ca2+]i increase (bin = 20 nM). C. Dose-dependent effects 
of DHEA-S pretreatment on average [Ca2+]i increase. After a 20-min incubation period at 37 °C with various DHEA-S concentrations, the average increase in [Ca2+]i within 
5 min of exposure to 20 µM AβP[25–35] was determined in hippocampal neurons cultured for 35 DIV from histograms in (B). As a control, the same DMSO concentration 
(0.5%) was added to the cultured neurons by the same protocol. Data are expressed as mean ± SEM, n = 250. * p   0.05, ** p   0.001. D. Effects of DHEA-S pretreatment 
on percentage of cells responding to AβP. The percentage of neurons responding to AβP[25–35] under the same conditions as those in (A) after pretreatment with various 
DHEA-S concentrations is analyzed from histograms in (B). Data are expressed as mean ± SEM, n = 5, * p   0.05.Neuropsychiatric Disease and Treatment 2008:4(1) 217
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